Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA400943
Max Phase: Preclinical
Molecular Formula: C13H7Cl2NO2
Molecular Weight: 280.11
Molecule Type: Small molecule
Associated Items:
ID: ALA400943
Max Phase: Preclinical
Molecular Formula: C13H7Cl2NO2
Molecular Weight: 280.11
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Oc1c(Cl)cc(-c2nc3ccccc3o2)cc1Cl
Standard InChI: InChI=1S/C13H7Cl2NO2/c14-8-5-7(6-9(15)12(8)17)13-16-10-3-1-2-4-11(10)18-13/h1-6,17H
Standard InChI Key: OTMWIJIZSYBHQF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 280.11 | Molecular Weight (Monoisotopic): 278.9854 | AlogP: 4.51 | #Rotatable Bonds: 1 |
Polar Surface Area: 46.26 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 5.64 | CX Basic pKa: 0.14 | CX LogP: 4.25 | CX LogD: 2.66 |
Aromatic Rings: 3 | Heavy Atoms: 18 | QED Weighted: 0.71 | Np Likeness Score: -1.05 |
1. Johnson SM, Connelly S, Wilson IA, Kelly JW.. (2008) Biochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors., 51 (2): [PMID:18095641] [10.1021/jm0708735] |
Source(1):